MedTrace Logo

BWH Critical Care Study of CareGuide for Evaluation of Emerging or Established Shock

NCT03060369 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-02-23

No results posted yet for this study

Summary

This pilot study aims to examine the relationship between continuously measured CareGuide™ muscle oxygen saturation (SmO2), tissue pH and data provided from standard monitoring techniques during the care of subjects with suspected established (Cohort A) or emerging (Cohort B) shock in the intensive care unit (ICU).

Conditions

  • Shock

Interventions

DEVICE

CareGuide™ device

CareGuide™ is a minimal risk, non-invasive device that uses near-infrared spectroscopy to measure skeletal muscle oxygen saturation.

Sponsors & Collaborators

  • Reflectance Medical, Inc.

    collaborator UNKNOWN

  • Brigham and Women's Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03060369 on ClinicalTrials.gov